Short answer
CONMED Corp (CNMD) filed its Q3 2026 10-Q quarterly report on Oct 28, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $336M (down 0.7% year over year) with net income of $20M.
Q3 2026 key financials · XBRL
- Revenue
- $336M
- −0.7% YoY · −49.2% QoQ
- Net income
- $20M
- +592.4% YoY · −46.4% QoQ
- Operating margin
- 11.1%
- Gross margin
- 56.4%
- EPS (diluted)
- $0.65
- +622.2% YoY · −46.7% QoQ
Source: XBRL data from the CONMED Corp (CNMD) Q3 2026 10-Q on SEC EDGAR. USD.
CONMED Corp Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $335.6M, down 0.7% YoY from $337.9M
- Gross margin 56.4% vs 49.2% YoY, operating margin 11.1% vs 3.5%
- Best segment orthopedic surgery: $148.8M, up 7.7%; worst general surgery: $186.7M, down 6.5%
- Operating cash flow $100.0M, down from $124.4M; capital expenditures $8.5M vs $14.7M
- Headwinds: inflation, supply-chain challenges, tariffs and higher variable-rate debt costs; potential cost reductions or refinancing ahead
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CONMED Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.